Evidence map›Paper›PMID 36085162›Full record

ArticleCommunications biology2022

SLITRK1-mediated noradrenergic projection suppression in the neonatal prefrontal cortex.

Minoru Hatayama, Kei-Ichi Katayama, Yukie Kawahara, Hayato Matsunaga, Noriko Takashima, Yoshimi Iwayama, Yoshifumi Matsumoto, Akinori Nishi, Takeo Yoshikawa, Jun Aruga

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Proteogenomic Analysis of Coronary Artery Calcification in Human Populations.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Minoru HatayamaDepartment of Medical Pharmacology, Nagasaki University Institute of Biomedical Sciences, Nagasaki, 852-8523, Japan.ORCID 0000-0001-7510-4769
Kei-Ichi KatayamaLaboratory for Behavioral and Developmental Disorders, RIKEN Brain Science Institute, Wako-shi, Saitama, 351-0198, Japan.
Yukie KawaharaDepartment of Pharmacology, Kurume University School of Medicine, Kurume-shi, Fukuoka, 830-0011, Japan.
Hayato MatsunagaDepartment of Medical Pharmacology, Nagasaki University Institute of Biomedical Sciences, Nagasaki, 852-8523, Japan.
Noriko TakashimaLaboratory for Behavioral and Developmental Disorders, RIKEN Brain Science Institute, Wako-shi, Saitama, 351-0198, Japan.
Yoshimi IwayamaLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako-shi, Saitama, 351-0198, Japan.
Yoshifumi MatsumotoLaboratory for Behavioral and Developmental Disorders, RIKEN Brain Science Institute, Wako-shi, Saitama, 351-0198, Japan.
Akinori NishiDepartment of Pharmacology, Kurume University School of Medicine, Kurume-shi, Fukuoka, 830-0011, Japan.ORCID 0000-0001-5056-5809
Takeo YoshikawaLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako-shi, Saitama, 351-0198, Japan.ORCID 0000-0003-2791-6679
Jun ArugaDepartment of Medical Pharmacology, Nagasaki University Institute of Biomedical Sciences, Nagasaki, 852-8523, Japan. aruga@nagasaki-u.ac.jp.ORCID 0000-0001-7936-1375
RIKEN Center for Brain Science · JPKurume University · JPNagasaki Institute of Applied Science · JPNagasaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SLITRK1 is an obsessive-compulsive disorder spectrum-disorders-associated gene that encodes a neuronal transmembrane protein. Here we show that SLITRK1 suppresses noradrenergic projections in the neonatal prefrontal cortex, and SLITRK1 functions are impaired by SLITRK1 mutations in patients with schizophrenia (S330A, a revertant of Homo sapiens-specific residue) and bipolar disorder (A444S). Slitrk1-KO newborns exhibit abnormal vocalizations, and their prefrontal cortices show excessive noradrenergic neurites and reduced Semaphorin3A expression, which suppresses noradrenergic neurite outgrowth in vitro. Slitrk1 can bind Dynamin1 and L1 family proteins (Neurofascin and L1CAM), as well as suppress Semaphorin3A-induced endocytosis. Neurofascin-binding kinetics is altered in S330A and A444S mutations. Consistent with the increased obsessive-compulsive disorder prevalence in males in childhood, the prefrontal cortex of male Slitrk1-KO newborns show increased noradrenaline levels, and serotonergic varicosity size. This study further elucidates the role of noradrenaline in controlling the development of the obsessive-compulsive disorder-related neural circuit.

Indexed as

NorepinephrinePrefrontal CortexAxonsHumansInfant, NewbornMaleMembrane ProteinsNerve Tissue ProteinsNeuritesNeuronal OutgrowthMembrane ProteinsNerve Tissue ProteinsNorepinephrineSLITRK1 protein, human

Identifiers

PMID36085162
PMCPMC9463131
OpenAlexW4295512325

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.